Search results
4 days ago · Aurobindo Pharma Share Price Today (19 Jul, 2024): Aurobindo Pharma Stock Price (₹ 1330.80) Live NSE/BSE updates on The Economic Times. Check out why Aurobindo Pharma share price is down today. Get all details on Aurobindo Pharma shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more
Apr 8, 2024 · Aurobindo Pharma share price | The share touched a 52-week high of Rs 1,177.00 and a 52-week low of Rs 517.55 on 30 January, 2024 and 05 April, 2023, respectively.
5 days ago · Shares of Aurobindo Pharma witnessed selling pressure on Thursday, with the share price falling over 2% in early trade after the drug maker announced share buyback worth up to ₹750 crore. The pharma company has fixed floor price for share buyback at ₹1,460 per share, a premium of 6.4% over Tuesday closing price of ₹1,371.70 on the BSE.
Nov 10, 2022 · Aurobindo Pharma is a leading pharmaceutical drug manufacturer in India, whereas Pernod Ricard is the manufacturer of alcoholic beverages Glenlivet, Chivas Regal and Ballentine's amongst others. The ED has alleged that Reddy was instrumental in the cartelization of liquor licenses. On Thursday, the shares of Aurobindo Pharma opened a tad lower at ₹538 as against the previous closing price of ₹541. During the session, it tumbled 13.75% to hit an intraday low of ₹464.
Aug 16, 2021 · Shares of Aurobindo Pharma hit a fresh 52-week low of Rs 728.50 as they fell 3.4 per cent on the BSE in intra-day trade on Tuesday. The stock of the pharmaceutical company has declined 12 per cent in the past three trading days after the company reported a disappointing operational performance in the June 2021 quarter (Q1FY22), amid a decline across the US market and antiretroviral (ARVs).
Jun 30, 2023 · Aurobindo Pharma shares fall as subsidiary undertakes facility restructuring The share touched a 52-week high of Rs 741.40 and a 52-week low of Rs 397.30 on 28 June, 2023 and 03 February, 2023 ...
Jul 15, 2024 · Here's Why Aurobindo Pharma (NSE:AUROPHARMA) Can Manage Its Debt Responsibly Jun 20. Price target increased by 7.9% to ₹1,292 May 30. Aurobindo Pharma Limited (NSE:AUROPHARMA) Released Earnings Last Week And Analysts Lifted Their Price Target To ₹1,271 ... Consensus EPS estimates fall by 11% Jun 06. Price target decreased to ₹734 Jun 01. Aurobindo Pharma Limited Announces Fourth Interim Dividend for the Financial Year 2021-22, Payable on or Before June 15, 2022
Get the latest Aurobindo Pharma Ltd (AUROPHARMA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
Feb 5, 2024 · Aurobindo Pharma shares fall 3% as USFDA issues 9 observation to subsidiary ... At 9.23 am, Aurobindo Pharma was quoting at Rs 1,030.55, down Rs 35.80, or 3.36 percent, on the BSE.
Sep 29, 2023 · Aurobindo Pharma shares scaled a 52-week high on Friday, more than recouping the previous day's losses, after sources said the company received approval to launch the Revlimid drug, used along with other medicines in the treatment of adult patients with multiple myeloma.
